Hematologic Malignancies
Since lymphoma is a cancer of the immune system, a major scientific goal of the Hematologic Malignancies Program is to use knowledge gained from immunology to understand and treat lymphoid malignancies. This goal is being accomplished by gaining better understanding of the biology underlying lymphoid and myeloid neoplasms and applying this knowledge to improve the diagnosis and treatment of these disorders.
Ravindra Majeti, MD, PhD
Director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine, RZ Cao Professor and Professor of Medicine (Hematology)
Gabriel Mannis, MD
Assistant Professor of Medicine (Hematology)
Everett Meyer, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy), of Pediatrics (Stem Cell Transplantation) and, by Courtesy, of Surgery (Abdominal Transplantation)
Beverly Mitchell, MD
George E. Becker Professor of Medicine (Oncology) and Professor, by Courtesy, of Chemical and Systems Biology
Lori Muffly, MD, MS
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Yasodha Natkunam, MD, PhD
Ronald F. Dorfman, MBBCH, FRCPATH Professor of Hematopathology
Robert Negrin, MD
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Andrew Rezvani, MD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Kathleen Sakamoto, MD, PhD
Shelagh Galligan Professor in the School of Medicine and Professor of Pediatrics (Hematology and Oncology)
Tait Shanafelt, MD
Jeanie and Stew Ritchie Professor of Medicine (Hematology)
Judith Shizuru, MD, PhD
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and of Pediatrics (Stem Cell Transplantation)
Robert Tibshirani, PhD
Professor of Biomedical Data Science and of Statistics
Robert Waymouth, PhD
Robert Eckles Swain Professor of Chemistry and Professor, by Courtesy, of Chemical Engineering
Kenneth Weinberg, MD
Anne T. and Robert M. Bass Professor of Pediatrics (Stem Cell Transplantation)
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by Courtesy, of Dermatology
1 2